---
figid: PMC9019764__etm-23-05-11287-g04
pmcid: PMC9019764
image_filename: etm-23-05-11287-g04.jpg
figure_link: /pmc/articles/PMC9019764/figure/f5-ETM-23-5-11287/
number: Figure 5
figure_title: ''
caption: Decrease in AKT phosphorylation levels induced by SIN is dependent on the
  decrease of VEGFR2 phosphorylation. (A) The inhibitory effect of SIN on VEGFR2 phosphorylation
  was similar to that of SU1498. n=3, ***P<0.001. (B) SIN inhibits VEGFR2-induced
  phosphorylation of AKT, which is reversible by IGF-1. n=3, *P<0.05, **P<0.01. SIN,
  sinensetin; VEGFR, vascular endothelial growth factor receptor; IGF-1, insulin-like
  growth factor 1.
article_title: Sinensetin suppresses angiogenesis in liver cancer by targeting the
  VEGF/VEGFR2/AKT signaling pathway.
citation: Xiao Li, et al. Exp Ther Med. 2022 May;23(5):360.
year: '2022'

doi: 10.3892/etm.2022.11287
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- sinensetin
- angiogenesis
- liver cancer
- human umbilical vascular endothelial cell
- molecular mechanism

---
